Aliases & Classifications for Cystadenoma

About this section

Aliases & Descriptions for Cystadenoma:

Name: Cystadenoma 10 47 12 36 65
Craniopharyngioma 65
 
Cystoma 10

Classifications:



External Ids:

Disease Ontology10 DOID:2634
MeSH36 D003537
SNOMED-CT59 189680006, 47620003
NCIt42 C2972
UMLS65 C0010633

Summaries for Cystadenoma

About this section
Wikipedia:68 Cystadenoma (or \"cystoma\") refers to a type of cystic adenoma. more...

MalaCards based summary: Cystadenoma, also known as craniopharyngioma, is related to ovarian cystadenoma and extrahepatic bile duct cystadenoma. An important gene associated with Cystadenoma is INHA (Inhibin Alpha), and among its related pathways is Peptide hormone metabolism. Affiliated tissues include breast, endothelial and thyroid, and related mouse phenotypes are tumorigenesis and renal/urinary system.

Disease Ontology:10 An adenoma that is a cystic.

Related Diseases for Cystadenoma

About this section

Diseases related to Cystadenoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 634)
idRelated DiseaseScoreTop Affiliating Genes
1ovarian cystadenoma34.1KRT20, KRT7, MUC1
2extrahepatic bile duct cystadenoma33.7CHGA, KRT20
3pancreatic cystadenoma33.6CHGA, KRT7, VHL
4ovarian cyst30.4KRT20, KRT7
5paget's disease of bone30.1CHGA, KRT20
6allergic contact dermatitis30.1CHGA, KRT20, KRT7
7hepatorenal syndrome30.0KRT20, KRT7, MME
8adjustment disorder29.9KRT20, KRT7, MUC6
9renal cell carcinoma29.2KIT, KRAS, KRT7, MME, VHL
10pancreatic serous cystadenoma12.4
11pancreatic mucinous cystadenoma12.4
12mucinous ovarian cystadenoma12.3
13bile duct cystadenoma12.3
14seminal vesicle cystadenoma12.2
15rete ovarii cystadenoma12.2
16ovarian papillary cystadenoma12.2
17intrahepatic bile duct cystadenoma12.2
18ovarian endometrioid cystadenoma12.2
19pancreatic colloid cystadenoma12.2
20uterine ligament papillary cystadenoma12.2
21serous or mucinous cystadenoma of childhood12.2
22hidrocystoma11.8
23ovarian serous cystadenocarcinoma11.5
24warthin tumor11.2
25absence of fingerprints congenital milia10.5INHA, MUC1
26lung large cell carcinoma10.5KRT20, KRT7
27autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to kiaa0226 deficiency10.5KRT7, VHL
28fasciitis10.5INHA, KRT20
29rete testis adenoma10.5KRT20, KRT7
30cervix erosion10.5KRT20, KRT7
31sphenoidal sinus cancer10.5KRT20, KRT7
32lacrimal gland mucoepidermoid carcinoma10.5KRT20, KRT7
33anal buschke-lowenstein tumor10.5KRT20, KRT7
34extraneural perineurioma10.5KIT, MUC1
35ovarian cancer10.5KRT20, MUC1
36follicular mucinosis10.5KRT20, KRT7
37testicular cancer10.4INHA, MUC1
38duodenum adenoma10.4KRT20, KRT7
39nodular tenosynovitis10.4KRT20, KRT7
40multifocal osteogenic sarcoma10.4KRT20, KRT7
41malignant teratocarcinosarcoma10.4KIT, MUC1
42acquired hemangioma10.4KRT20, KRT7
43prostate malignant phyllodes tumor10.4KRT20, KRT7
44vulva adenocarcinoma10.4KRT20, KRT7
45heel spur10.4KRT20, KRT7
46benign mesothelioma10.4KIT, MUC1
47sarcomatoid mesothelioma10.4KRT20, KRT7
48benign vaginal carcinosarcoma10.4KIT, KRT20
49ovarian mucinous cystadenocarcinoma10.4KRT20, MUC1
50childhood choriocarcinoma of the ovary10.4BRCA1, KRT7

Graphical network of the top 20 diseases related to Cystadenoma:



Diseases related to cystadenoma

Symptoms for Cystadenoma

About this section

Drugs & Therapeutics for Cystadenoma

About this section

Drugs for Cystadenoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1Phase 2, Phase 3, Phase 1
2AnestheticsPhase 37385
3
PancrelipaseapprovedPhase 2, Phase 088053608-75-6
Synonyms:
1,4-alpha-D- glucan glucanohydrolase
Creon
PA
Pancreatic alpha-amylase precursor
Pancreaze
 
Pancrelipase
Pertzye
Polocaine-mpf
Ultresa
Viokace
Zenpep
4pancreatinPhase 2, Phase 0880
5
PaclitaxelapprovedPhase 1262133069-62-436314
Synonyms:
(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
157069-30-2
33069-62-4
5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.
7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.
7-Epi-Paclitaxel
7-Epi-Taxol
7-Epipaclitaxel
7-Epitaxol
7-epi-Paclitaxel
7-epi-Taxol
AB00513812
ABI 007
ABI-007
ABI007
AC-675
AC1L1IOG
AC1L1VJI
AC1L9AVF
ACon1_002231
ANX-513
Abraxane
Abraxane (TN)
Abraxane I.V. Suspension
Abraxis BioScience brand of albumin-bound paclitaxel
Ambotz33069-62-4
Anzatax
Asotax
BIDD:PXR0046
BMS 181339-01
BMS-181339
BMS-181339-01
BPBio1_000320
BRD-A23723433-001-01-2
BRD-A28746609-001-04-0
BRD-K62008436-001-03-1
BSPBio_000290
BSPBio_001152
BSPBio_002614
Bio-0076
Bio1_000362
Bio1_000851
Bio1_001340
Bio2_000416
Bio2_000896
Bristaxol
C07394
C466458
C47H51NO14
CCRIS 8143
CHEBI:103439
CHEBI:45863
CHEMBL100910
CHEMBL418410
CHEMBL48
CID36314
CID441276
CID4666
CID6713921
CID6915727
CPD-8718
Capxol
D00491
DB01229
DHP-107
DHP-208
DRG-0190
DTS-301
DivK1c_000441
EU-0101201
Ebetaxel
EmPAC
Epitaxol
Genaxol
Genetaxyl
Genexol
Genexol-PM
HMS1362J13
HMS1568O12
HMS1792J13
HMS1922K08
HMS1990J13
HMS2090D07
HMS2093K15
HMS501G03
HSDB 6839
I06-0014
IDI1_000441
IDI1_002171
Intaxel
KBio1_000441
KBio2_000492
KBio2_002016
KBio2_002509
KBio2_003060
KBio2_004584
KBio2_005077
KBio2_005628
KBio2_007152
KBio2_007645
KBio3_000903
KBio3_000904
KBio3_001834
KBio3_002987
KBioGR_000492
KBioGR_001893
 
KBioGR_002509
KBioSS_000492
KBioSS_002016
KBioSS_002517
LMPR0104390001
LS-31070
LipoPac
Lopac0_001201
MBT 0206
MEGxp0_001940
MLS000863266
MLS001077297
MLS002154218
MLS002172439
MLS002695976
MPI-5018
Micellar Paclitaxel
Mitotax
MolPort-001-742-627
MolPort-003-665-783
MolPort-003-932-365
NCGC00024995-02
NCGC00024995-03
NCGC00024995-04
NCGC00024995-05
NCGC00024995-06
NCGC00024995-07
NCGC00164367-01
NCGC00164367-02
NCGC00164367-03
NCI60_000601
NINDS_000441
NK 105
NP-010981
NSC 125973
NSC-125973
NSC125973
NSC358882
Nanotaxel
Neuro_000060
Nova-12005
OAS-PAC-100
OncoGel
Onxal
Onxol
Onxol, Taxol, Nov-Onxol, Paclitaxel
P1632
Paclical
Pacligel
Paclitaxel
Paclitaxel (JAN/USP)
Paclitaxel (JAN/USP/INN)
Paclitaxel (Taxol)
Paclitaxel [USAN:INN:BAN]
Paxceed
Paxene
Paxoral
Plaxicel
Praxel
Prestwick0_000155
Prestwick1_000155
Prestwick2_000155
Prestwick3_000155
Probes2_000350
QW 8184
S-8184 Paclitaxel Injectable Emulsion
S1150_Selleck
SDCCGMLS-0066823.P001
SDP-013
SMP1_000228
SMR000394086
SMR000857385
SPBio_000943
SPBio_002229
SPECTRUM1503908
ST50306996
Spectrum2_000872
Spectrum3_001057
Spectrum4_001197
Spectrum5_001491
Spectrum_001536
T 7402
T1912_SIGMA
T7191_SIGMA
T7402_SIGMA
TA1
TAXOL (TN)
TAXOL, 10-EPI,
TXL
TaxAlbin
Taxol
Taxol A
Taxol Konzentrat
Taxol.RTM. (Registered Trademark)
UNII-P88XT4IS4D
UPCMLD-DP108:001
UPCMLD-DP108:002
Vascular Wrap
Xorane
Yewtaxan
abi-007
albumin-bound paclitaxel
cMAP_000068
nchembio.188-comp1
nchembio.2007.34-comp9
nchembio.215-comp9
nchembio853-comp6
paclitaxel
weekly paclitaxel
6Albumin-Bound PaclitaxelPhase 12621
7Central Nervous System DepressantsPhase 110016
8Antineoplastic Agents, PhytogenicPhase 14294
9Tubulin ModulatorsPhase 14279
10Antibiotics, AntitubercularPhase 15971
11Anti-Bacterial AgentsPhase 19140
12Anti-Infective AgentsPhase 117220
13Anti-Infective Agents, LocalPhase 1984
14Antimitotic AgentsPhase 14296

Interventional clinical trials:

idNameStatusNCT IDPhase
1EUS-Guided Pancreatic Injection of Cyst (EPIC) TrialCompletedNCT00233038Phase 2, Phase 3
2Efficacy and Safety of Radiofrequency Ablation in Pancreatic Neuroendocrine and Cystic TumorRecruitingNCT02330497Phase 3
3Laser Therapy of Benign Thyroid NodulesActive, not recruitingNCT00150150Phase 3
4Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic CystectomyNot yet recruitingNCT02097446Phase 3
5A Phase II MULTICENTRE Trial of Needle Based Laser Confocal Endomicroscopy of Cystic and Solid Tumours of the PancreasRecruitingNCT02523170Phase 2
6Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic NeoplasmRecruitingNCT01525706Phase 1
7Ovarian Clear Cell Adenocarcinoma ReviewCompletedNCT02129036
8Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic CystsRecruitingNCT01643460
9Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic LesionsRecruitingNCT02494388Phase 0
10Collecting Tumor Samples From Patients With Gynecological TumorsRecruitingNCT00897442

Search NIH Clinical Center for Cystadenoma


Cochrane evidence based reviews: cystadenoma

Genetic Tests for Cystadenoma

About this section

Anatomical Context for Cystadenoma

About this section

MalaCards organs/tissues related to Cystadenoma:

33
Breast, Endothelial, Thyroid, Heart, Bone, Lung, Pancreas

Animal Models for Cystadenoma or affiliated genes

About this section

MGI Mouse Phenotypes related to Cystadenoma:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.3BRCA1, INHA, KIT, KRAS, VHL
2MP:00053677.5BRCA1, CHGA, KIT, KRAS, KRT7, VHL

Publications for Cystadenoma

About this section

Articles related to Cystadenoma:

(show top 50)    (show all 702)
idTitleAuthorsYear
1
Body mass index can affect gastrointestinal and genitourinary toxicity in patients with prostate cancer treated with external beam radiation therapy. (24348850)
2014
2
Mutations in GATA2 are rare in juvenile myelomonocytic leukemia. (24578498)
2014
3
Three-dimensional contrast-enhanced sonography in the assessment of breast tumor angiogenesis: correlation with microvessel density and vascular endothelial growth factor expression. (24764339)
2014
4
One-staged silicone implant breast reconstruction following bilateral nipple-sparing prophylactic mastectomy in patients at high-risk for breast cancer. (23322096)
2013
5
Sleep-Wake profiles in patients with primary biliary cirrhosis. (23173839)
2013
6
Treatment of Chronic SFA In-Stent Occlusion With Combined Laser Atherectomy and Drug-Eluting Balloon Angioplasty in Patients With Critical Limb Ischemia: A Single-Center, Prospective, Randomized Study. (24325697)
2013
7
Kisspeptin and puberty in mammals. (23550010)
2013
8
Combined mutational analysis of KRAS, NRAS and BRAF genes in Indian patients with colorectal carcinoma. (22427190)
2012
9
Chronic rhinitis: a manifestation of leprosy. (21938685)
2011
10
BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer. (21409391)
2011
11
Roles of POLD4, smallest subunit of DNA polymerase delta, in nuclear structures and genomic stability of human cells. (19931513)
2010
12
CACNA1C (rs1006737) is associated with schizophrenia. (20098439)
2010
13
Bone morphogenetic protein (BMP)-7 expression is decreased in human hypertensive nephrosclerosis. (21080950)
2010
14
INO80 chromatin remodeling complex promotes the removal of UV lesions by the nucleotide excision repair pathway. (20855601)
2010
15
Distinct amino termini of two human HCS isoforms influence biotin acceptor substrate recognition. (19740736)
2009
16
Chronic lymphoedema complicated by septic arthritis of the hip. (19298275)
2009
17
The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway. (17700518)
2008
18
Brown-SAcquard syndrome secondary to spontaneous bleed from postradiation cavernous angiomas. (18617590)
2008
19
Serotonin 1A receptors in human and monkey prefrontal cortex are mainly expressed in pyramidal neurons and in a GABAergic interneuron subpopulation: implications for schizophrenia and its treatment. (18761712)
2008
20
Prevalence of hypopituitarism in patients with cerebrovascular diseases. (19020380)
2008
21
Alternative transcripts of Dclk1 and Dclk2 and their expression in doublecortin knockout mice. (18075264)
2008
22
Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC. (18417666)
2008
23
Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: relationships between prostate-specific antigen, pain, and quality of life response and survival in the TAX-327 study. (18451243)
2008
24
Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma. (17676389)
2007
25
Positron emission tomography for predicting malignancy of sinonasal inverted papilloma. (17413572)
2007
26
Differentiation of adipose-derived stem cells induced by recombinant adenovirus's containing fibers derived from B-group serotype 35-mediated bone morphogenetic protein]. (17357457)
2007
27
Decreased expression of RIZ1 and its clinicopathological significance in epithelial ovarian carcinoma: correlation with epigenetic inactivation by aberrant DNA methylation. (17922684)
2007
28
A randomized trial of long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria. (16483397)
2006
29
Participation of superoxide in neutrophil activation and cytokine production. (16919916)
2006
30
Primary adenosquamous carcinoma of the jejunum. (16143036)
2005
31
Near-triploidy and near-tetraploidy in hematological malignancies and mutation of the p53 gene. (14738434)
2004
32
How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration. (12808446)
2003
33
Resveratrol inhibits matrix metalloproteinase-9 transcription in U937 cells. (14627504)
2003
34
Sudden infant death syndrome: is it a transepithelial transport disorder? (12323127)
2002
35
Hereditary neuropathy with liability to pressure palsies: a case report. (11302321)
2001
36
Molecular genetics of neuroendocrine tumors. (10940682)
2000
37
sICAM-1, sCD95 and sCD95L levels in chronic liver diseases of different etiology. (10737254)
2000
38
Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells. (10395947)
1999
39
The structure in solution of the B domain of protein disulfide isomerase. (10383197)
1999
40
The effect of different thawing methods, growth factor combinations and media on the ex vivo expansion of umbilical cord blood primitive and committed progenitors. (9489645)
1998
41
Affinity purification of human DNA repair/transcription factor TFIIH using epitope-tagged xeroderma pigmentosum B protein. (9422774)
1998
42
Aggressive therapeutic amniocentesis for treatment of twin-twin transfusion syndrome. (2002975)
1991
43
Bryostatin 1: a potential anti-leukemic agent for chronic myelomonocytic leukemia. (2027297)
1991
44
Patterns of serum alkaline phosphatase activity in unilateral hepatic duct obstruction: a clinical and experimental study. (2300898)
1990
45
Regulation of the human T-cell receptor alpha gene enhancer: multiple ubiquitous and T-cell-specific nuclear proteins interact with four hypomethylated enhancer elements. (2388624)
1990
46
Controlling for cerebral atrophy in positron emission tomography data. (2956273)
1987
47
Papilledema related to left cerebral hemisphere abscess in a heifer. (4491122)
1973
48
49
50

Variations for Cystadenoma

About this section

Expression for genes affiliated with Cystadenoma

About this section
Search GEO for disease gene expression data for Cystadenoma.

Pathways for genes affiliated with Cystadenoma

About this section

Pathways related to Cystadenoma according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.6CHGA, INHA, MME

GO Terms for genes affiliated with Cystadenoma

About this section

Biological processes related to Cystadenoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1mast cell chemotaxisGO:00025519.8CHGA, KIT
2mast cell degranulationGO:00433039.4CHGA, KIT
3DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorGO:00069789.3BRCA1, MUC1

Sources for Cystadenoma

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet